Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Hsieh Anthony Li LDI loanDepot, Inc. 13D/A 63% 2y
INCLUSIVE CAPITAL PARTNERS, L.P. STRA Strategic Education, Inc. 13D/A 4.8% 2y
Harborne Christopher IA Innovative Solutions & Support Inc 13D/A 14.9% 2y
Martin Resource Management Corporation MMLP Martin Midstream Partners L.P. 13D/A 15.7% 2y
Osmium Partners, LLC TBHC BRAND HOUSE COLLECTIVE, INC. 13D/A 9.8% 2y
Tencent Holdings Limited LILMF Lilium N.V. 13D/A 23.36% 2y
Ruben S. Martin, III MMLP Martin Midstream Partners L.P. 13D/A 25.6% 2y
Millstreet Capital Management LLC DBD DIEBOLD NIXDORF, Inc 13D/A 16.04% 2y
Pershing Square Capital Management, L.P. HHH Howard Hughes Holdings Inc. 13D/A 37.5% 2y
GK Investor LLC GNK Genco Shipping & Trading Ltd 13D/A 0.6% 2y
GAMCO INVESTORS, INC. ET AL SCX The L.S. Starrett Company 13D/A 0% 2y
Arisaig Partners (Asia) Pte Ltd. IH iHuman Inc. 13G/A 5.7% 2y
Comcast Ventures, LP BZFD BuzzFeed, Inc. 13D/A 5.68% 2y
Flagship Ventures Fund V, L.P. FHTX Foghorn Therapeutics Inc. 13D/A 22.9% 2y
Fund 1 Investments, LLC CTRN Citi Trends Inc 13D/A 24.8% 2y
York Capital Management Global Advisors, LLC NEXT NextDecade Corp 13D/A 15.2% 2y
RC Ventures LLC GME GameStop Corp. 13D/A 10.5% 2y
Ned N. Fleming, IV ROAD Construction Partners, Inc. 13D/A 1.1% 2y
Gulf Hungary Holding Korlatolt Felelossegu Tarsasag KWR Quaker Chemical Corp 13D/A 22.3% 2y
SEQUOIA CAPITAL ISRAEL IV HOLDINGS, L.P. (“SEQUOIA CAPITAL ISRAEL IV HOLDINGS”) CTV Innovid Corp. 13G/A 6.7% 2y
AECOM SHIM Shimmick Corp 13D 16.7% 2y
ATW Opportunities Master Fund, L.P. FRGT Freight Technologies, Inc. 13G/A 9.9% 2y
F. Hurst Lin (“Lin”) GCT GigaCloud Technology Inc 13D/A 15.9% 2y
Nikolaos Vafias CISS C3is Inc. 13G 8.5% 2y
Beryl Capital Management LLC SCX The L.S. Starrett Company 13G 6.9% 2y
Third Point LLC CNK Cinemark Holdings, Inc. 13G 5.7% 2y
FIG LLC NN Nextnav Inc. 13G 11.75% 2y
Nextech Crossover I GP S.a. r.l. CNTX Context Therapeutics Inc. 13G 9.9% 2y
Eric Healy BOF BranchOut Food Inc. 13G 20.3% 2y
David Israel BOF BranchOut Food Inc. 13G 6.9% 2y
Atlas Investissement SAS TIGO Millicom International Cellular SA 13D/A 29.19% 2y
Bristol Investment Fund, Ltd. GTBP GT Biopharma, Inc. 13G/A 8.8% 2y
George Doumet USLM United States Lime & Minerals Inc 13D/A 61.84% 2y
GAMCO INVESTORS, INC. ET AL TSAT Telesat Corp 13D/A 14.99% 2y
SCHULER JACK W BDSX Biodesix Inc 13D/A 21.4% 2y
Great Hill Equity Partners IV, L.P. INTA Intapp, Inc. 13D/A 0% 2y
Lawrence T. Kennedy, Jr. BDSX Biodesix Inc 13D/A 17.6% 2y
A. Lorne Weil INSE Inspired Entertainment, Inc. 13D/A 10.2% 2y
Oaktree Capital Holdings, LLC VCSA Vacasa, Inc. Class A Common Stock 13D 8.99% 2y
Topline Capital Management, LLC KRMD KORU Medical Systems, Inc. 13G 5.9% 2y
J. Wood Capital Advisors LLC KPTIQ Karyopharm Therapeutics Inc. 13G 5.5% 2y
Cowen Financial Products LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G/A 9.89% 2y
Cactus Healthcare Management LP CCTSF Cactus Acquisition Corp. 1 Ltd 13G/A 12.5% 2y
SCHULER JACK W AXDX Accelerate Diagnostics, Inc. 13D/A 45.4% 2y
Ned L. Sherwood BRN Barnwell Industries Inc 13D/A 29.69% 2y
Cloud Alliance Inc QH QUHUO Ltd 13D/A 25.96% 2y
Kimmeridge Energy Management Company, LLC SBOW SilverBow Resources, Inc. 13D/A 12.8% 2y
Bleichroeder LP INVE INVE Technologies, Inc. 13D/A 19.9% 2y
SRK FUND I, LP ICCC Immucell Corp 13D 5% 2y
Coliseum Capital Management, LLC MCFT MasterCraft Boat Holdings, Inc. 13D/A 16.9% 2y